Christoph Thomas Ellebrecht, MD

faculty photo
Assistant Professor of Dermatology
Department: Dermatology
Graduate Group Affiliations

Contact information
Department of Dermatology
421 Curie Boulevard
Philadelphia, PA 19104
Office: 2158982633
Medizinische Hochschule Lübeck, University Lübeck, Germany , 2011.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

As a board-certified dermatologist and physician-scientist, my expertise encompasses a wide range of skin-related medical conditions, with a particular emphasis on autoimmune blistering diseases such as pemphigus, bullous pemphigoid, and mucous membrane pemphigoid. My comprehensive understanding of the pathophysiology, clinical presentation, diagnosis, and management of these disorders has positioned me as an expert in the field of dermatology and immunology.

As an academic dermatologist, my role extends beyond research to encompass clinical care, education, and mentoring. I have been dedicated to providing compassionate, evidence-based care to patients suffering from autoimmune blistering diseases, tailoring treatments to their individual needs and circumstances. I have also been actively involved in teaching and mentoring medical students, residents, and fellows, sharing my knowledge and experience in the field of dermatology and inspiring the next generation of physician-scientists.

Description of Research Expertise

Throughout my scientific career, I have been dedicated to understanding immune cells in relation to autoimmunity and utilizing them for precision cellular immunotherapies. My recently founded lab focuses on exploring how and when specialized human immune cells, used for treating patients or residing in specific organs, commit to long-lasting or short-term cell fates. I am especially intrigued by T lymphocytes and their memory abilities, which allow them to respond faster and more effectively when re-exposed to a pathogen.

While immune memory is an abstract concept, its cellular basis lies in the formation of specialized memory T lymphocytes. The processes by which human T cells become memory T cells at the cellular and molecular levels are not yet understood. However, in mice, memory T cells are generated through asymmetric partitioning after T cell activation. During this process, the T cell closer to the antigen-presenting cell becomes a short-lived effector cell, while the T cell further away becomes a long-lived memory T cell. These events, occurring within a limited time window between T cell activation and first cell division, present a fascinating area of study and manipulation. This proposal's main scientific goal is to shed light on this process in specialized human T cells used to treat cancer (CAR) or autoimmune disease (CAAR).

As a research fellow at the University of Pennsylvania, I studied the antibody response and analyzed the connections between antibody isotypes and subclasses in the autoimmune skin disorder pemphigus vulgaris. Moreover, I investigated broadly neutralizing antibodies to HIV in the context of chimeric antigen receptor (CAR)-engineered T cells. I also developed chimeric autoantibody receptors (CAARs), inspired by the successful CAR T cell approach, which enables specific targeting of autoreactive B cells based on their B cell receptor autoreactivity. Currently being tested in first-in-human clinical trials, CAAR therapy represents the first precision cellular immunotherapy for human autoimmune disease.
Consequently, my comprehensive experience in human T cell engineering and translational studies of human autoimmunity is well-aligned with the research goals and methodologies of my laboratory, showcasing my expertise as a translational immunologist.

Selected Publications

Christoph Ellebrecht, Aimee Payne: Pemphigus. Fitzpatrick's Dermatology 10th edition 2025.

Corbett Berry, Casey Lee, Sisi Chen, Caitlin Frazee, Patrick Herman, Anna Chen, Andre Kelly, Roderick O'Connor, Christoph Ellebrecht: Asymmetric epigenetic and metabolic remodeling of engineered CD4 T cells drives divergent cell fate. Society of Investigative Dermatology 2024.

Chat, Vipawee S. Ellebrecht, Christoph T. Kingston, Paige Gondo, George Bell, Stacie Cordoro, Kelly M. Desai, Seemal R. Duffin, Kristina C. Feldman, Steven R. Garg, Amit Gelfand, Joel M. Gladman, Dafna Green, Lawrence J. Gudjonsson, Johann Han, George Hawkes, Jason E. Kircik, Leon Koo, John Langley, Richard Lebwohl, Mark Michael Lewitt, G. Liao, Wilson Martin, George Orbai, Ana-Maria Reddy, Soumya M. Richardson, Veronica Ritchlin, Christopher T. Schwartzman, Sergio Siegel, Evan L. Van Voorhees, Abby S. Wallace, Elizabeth B. Weinberg, Jeffrey M. Winthrop, Kevin L. Yamauchi, Paul Armstrong, April W.: Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation. Journal of the American Academy of Dermatology 2024.

Oh S, Mao X, Manfredo-Vieira S, Lee J, Patel D, Choi EJ, Alvarado A, Cottman-Thomas E, Maseda D, Tsao PY, Ellebrecht CT, Khella SL, Richman DP, O'Connor KC, Herzberg U, Binder GK, Milone MC, Basu S, Payne AS.: Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells. Nat Biotechnol. 2023.

Christoph T. Ellebrecht, Aimee S. Payne: Fitzpatrick's Therapeutics: A Clinician's Guide to Dermatologic Treatment. \{Fitzpatrick's Therapeutics: A Clinician's Guide to Dermatologic Treatment, 1st Edition, McGraw Hill} 2023.

Christoph T. Ellebrecht, Casey Lee, Roderick O'Connor, Aimee S. Payne: Asymmetric cell division for fate induction of chimeric antigen receptor (CAR) T cells. Journal of Investigative Dermatology, Volume 142, Issue 8, Supplement, 2022. 2022.

Christoph T Ellebrecht, Casey Lee, Roderick O'Connor, Aimee S. Payne: Asymmetric cell division for fate induction of chimeric antigen receptor (CAR) T cells Annual Conference of the American Society for Gene and Cell Therapy 2022.

Ellebrecht CT, Maseda D, Payne AS. : Pemphigus and Pemphigoid: From Disease Mechanisms to Druggable Pathways. J Invest Dermatol. 2022.

Wat M, Mollanazar NK, Ellebrecht CT, Forrestel A, Elenitsas R, Chu EY. : Lichen-planus-pemphigoides-like reaction to PD-1 checkpoint blockade. J Cutan Pathol. 2022.

Ellebrecht, C.T.: Engineering chimeric antigen receptor (CAR) T cells for treatment of γδ T cell lymphomas Society for Investigative Dermatology Annual Meeting 2021: 2021.

back to top
Last updated: 04/24/2024
The Trustees of the University of Pennsylvania